SG11202105686UA - Therapeutic agent of peripheral blood flow disorder - Google Patents
Therapeutic agent of peripheral blood flow disorderInfo
- Publication number
- SG11202105686UA SG11202105686UA SG11202105686UA SG11202105686UA SG11202105686UA SG 11202105686U A SG11202105686U A SG 11202105686UA SG 11202105686U A SG11202105686U A SG 11202105686UA SG 11202105686U A SG11202105686U A SG 11202105686UA SG 11202105686U A SG11202105686U A SG 11202105686UA
- Authority
- SG
- Singapore
- Prior art keywords
- therapeutic agent
- blood flow
- peripheral blood
- flow disorder
- disorder
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
- A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Cardiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Reproductive Health (AREA)
- Biomedical Technology (AREA)
- Gynecology & Obstetrics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018225295 | 2018-11-30 | ||
| PCT/JP2019/046847 WO2020111249A1 (ja) | 2018-11-30 | 2019-11-29 | 末梢血流障害の治療剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202105686UA true SG11202105686UA (en) | 2021-06-29 |
Family
ID=70853028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202105686UA SG11202105686UA (en) | 2018-11-30 | 2019-11-29 | Therapeutic agent of peripheral blood flow disorder |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220000936A1 (ko) |
| EP (1) | EP3888751B1 (ko) |
| JP (1) | JP7473207B2 (ko) |
| KR (1) | KR20210099014A (ko) |
| CN (1) | CN113195054A (ko) |
| AU (1) | AU2019388016A1 (ko) |
| CA (1) | CA3121444A1 (ko) |
| SG (1) | SG11202105686UA (ko) |
| WO (1) | WO2020111249A1 (ko) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9550975B2 (en) | 2009-07-15 | 2017-01-24 | Mari Dezawa | SSEA-3 pluripotent stem cell isolated from body tissue |
| WO2012024296A1 (en) * | 2010-08-20 | 2012-02-23 | University Of Miami | Arterial repair with cultured bone marrow cells and whole bone marrow |
| CN102641297B (zh) * | 2011-02-21 | 2016-02-24 | 杨子江 | 治疗外周动脉粥样硬化引起的缺血性疾病的制剂及其制备方法 |
| ES2882702T3 (es) * | 2016-07-29 | 2021-12-02 | Univ Tohoku | Células "Muse" como agente profiláctico o terapéutico para el aneurisma |
-
2019
- 2019-11-29 JP JP2020557865A patent/JP7473207B2/ja active Active
- 2019-11-29 SG SG11202105686UA patent/SG11202105686UA/en unknown
- 2019-11-29 KR KR1020217018397A patent/KR20210099014A/ko unknown
- 2019-11-29 CN CN201980078419.XA patent/CN113195054A/zh active Pending
- 2019-11-29 EP EP19891644.7A patent/EP3888751B1/en active Active
- 2019-11-29 CA CA3121444A patent/CA3121444A1/en active Pending
- 2019-11-29 US US17/298,367 patent/US20220000936A1/en active Pending
- 2019-11-29 WO PCT/JP2019/046847 patent/WO2020111249A1/ja unknown
- 2019-11-29 AU AU2019388016A patent/AU2019388016A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020111249A1 (ja) | 2020-06-04 |
| EP3888751A1 (en) | 2021-10-06 |
| EP3888751A4 (en) | 2022-10-05 |
| JPWO2020111249A1 (ko) | 2020-06-04 |
| US20220000936A1 (en) | 2022-01-06 |
| CA3121444A1 (en) | 2020-06-04 |
| JP7473207B2 (ja) | 2024-04-23 |
| KR20210099014A (ko) | 2021-08-11 |
| AU2019388016A1 (en) | 2021-07-08 |
| CN113195054A (zh) | 2021-07-30 |
| EP3888751B1 (en) | 2024-04-17 |
| EP3888751C0 (en) | 2024-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20190117T1 (hr) | iRNK TERAPIJA ZA LIJEČENJE BOLESTI OKA | |
| IL280707A (en) | Diagnostic and therapeutic methods for treating breast cancer | |
| ZA201908165B (en) | Compounds for the prevention and treatment of diseases and the use thereof | |
| IL258854A (en) | Preparations containing cannabidiol and secondary medicinal agents for cancer treatment | |
| EP3416547A4 (en) | FACILITATION OF EVALUATION OF BLOOD FLOW AND TISSUE PERFUSION BY FLUORESCENCE-MEDIATED PHOTOPLETHYSMOGRAPHY | |
| IL292810A (en) | Therapeutic compounds and methods of use | |
| EP3253451A4 (en) | Diagnosis and treatment of chronic pain | |
| IL272097A (en) | Compounds for the prevention and treatment of medical disorders and their uses | |
| GB201918879D0 (en) | Treatment of chronic pain | |
| IL291372A (en) | Treatment of chronic granulomatous disease | |
| GB202015959D0 (en) | Treatment of diseases involving NAD | |
| EP3831844C0 (en) | DIAGNOSIS AND THERAPY OF MULTIPLE SCLEROSIS | |
| GB201805100D0 (en) | Treatment of sarcopenic diseases | |
| IL270140B (en) | A therapeutic agent for blood cancer | |
| GB201820994D0 (en) | Methods of treatment and diagnosis of tumours | |
| GB201717625D0 (en) | Device for treatment of chronic respiratory diseases | |
| GB201813312D0 (en) | Compounds and their therapeutic use | |
| GB201412842D0 (en) | Catheter for the delivery of therapeutic fluid | |
| SG11202105686UA (en) | Therapeutic agent of peripheral blood flow disorder | |
| PL3431119T3 (pl) | Aparat do pozaustrojowego oczyszczania krwi | |
| EP4031667C0 (en) | CA-IX APTAMERS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF | |
| IL275150A (en) | System for hypothermia treatment of a patient | |
| GB201812861D0 (en) | Methods of administering therapy | |
| PL3582764T3 (pl) | Leczenie zaburzeń związanych ze spożywaniem alkoholu | |
| IL275152A (en) | System for hypothermia treatment of a patient |